Science and Research

Secondary crest myofibroblast PDGFRalpha controls the elastogenesis pathway via a secondary tier of signaling networks during alveologenesis

Postnatal alveolar formation is the most important and the least understood phase of lung development. Alveolar pathologies are prominent in neonatal and adult lung diseases. The mechanisms of alveologenesis remain largely unknown. We inactivated Pdgfra postnatally in secondary crest myofibroblasts (SCMF), a subpopulation of lung mesenchymal cells. Lack of Pdgfra arrested alveologenesis akin to bronchopulmonary dysplasia (BPD), a neonatal chronic lung disease. The transcriptome of mutant SCMF revealed 1808 altered genes encoding transcription factors, signaling and extracellular matrix molecules. Elastin mRNA was reduced, and its distribution was abnormal. Absence of Pdgfra disrupted expression of elastogenic genes, including members of the Lox, Fbn and Fbln families. Expression of EGF family members increased when Tgfb1 was repressed in mouse. Similar, but not identical, results were found in human BPD lung samples. In vitro, blocking PDGF signaling decreased elastogenic gene expression associated with increased Egf and decreased Tgfb family mRNAs. The effect was reversible by inhibiting EGF or activating TGFbeta signaling. These observations demonstrate the previously unappreciated postnatal role of PDGFA/PDGFRalpha in controlling elastogenic gene expression via a secondary tier of signaling networks composed of EGF and TGFbeta.

  • Li, C.
  • Lee, M. K.
  • Gao, F.
  • Webster, S.
  • Di, H.
  • Duan, J.
  • Yang, C. Y.
  • Bhopal, N.
  • Peinado, N.
  • Pryhuber, G.
  • Smith, S. M.
  • Borok, Z.
  • Bellusci, S.
  • Minoo, P.

Keywords

  • Alveolar formation
  • Elastogenesis
  • Human
  • Lung development
  • Mouse
  • Pdgfra
  • Secondary crest myofibroblast
Publication details
DOI: 10.1242/dev.176354
Journal: Development
Number: 15
Work Type: Original
Location: UGMLC
Disease Area: General Lung and Other
Partner / Member: JLU
Access-Number: 31331942
See publication on PubMed

DZL Engagements

chevron-down